Literature DB >> 17366630

Hyperoxia inhibits several critical aspects of vascular development.

Koichi Uno1, Carol A Merges, Rhonda Grebe, Gerard A Lutty, Tarl W Prow.   

Abstract

Normal human retinal vascular development uses angiogenesis and vasculogenesis, both of which are interrupted in the vaso-obliteration phase of retinopathy of prematurity (ROP). Canine oxygen-induced retinopathy (OIR) closely resembles human ROP. Canine retinal endothelial cells (ECs) and angioblasts were used to model OIR and characterize the effects of hyperoxia on angiogenesis and vasculogenesis. Cell cycle analysis showed that hyperoxia reduced the number of G1 phase cells and showed increased arrest in S phase for both cell types. Migration of ECs was significantly inhibited in hyperoxia (P < 0.01). Hyperoxia disrupted the cytoskeleton of angioblasts but not ECs after 2 days. Differentiation of angioblasts into ECs (determined by acetylated low-density lipoprotein uptake) was evaluated after basic fibroblast growth factor treatment. Differentiation of angioblasts into pericytes was determined by smooth muscle actin expression after treatment with platelet-derived growth factor. Differentiation into ECs was significantly inhibited by hyperoxia (P < 0.0001). The percentage of CXCR4(+) cells (a marker for retinal vascular precursors) increased in both treatment groups after hyperoxia. These data show novel mechanisms of hyperoxia-induced disruption of vascular development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17366630      PMCID: PMC4942183          DOI: 10.1002/dvdy.21122

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  35 in total

1.  Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis.

Authors:  S Hughes; H Yang; T Chan-Ling
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-04       Impact factor: 4.799

Review 2.  The International Classification of Retinopathy of Prematurity revisited.

Authors: 
Journal:  Arch Ophthalmol       Date:  2005-07

3.  Effects of hyperoxia on microvascular cells in vitro.

Authors:  P A D'Amore; E Sweet
Journal:  In Vitro Cell Dev Biol       Date:  1987-02

4.  Visualization of a developing vasculature.

Authors:  D S McLeod; G A Lutty; S D Wajer; R W Flower
Journal:  Microvasc Res       Date:  1987-03       Impact factor: 3.514

5.  Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1.

Authors:  Ombretta Salvucci; Lei Yao; Sabrina Villalba; Agatha Sajewicz; Stefania Pittaluga; Giovanna Tosato
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

6.  Screening guidelines for retinopathy of prematurity: the need for revision in extremely low birth weight infants.

Authors:  M Subhani; A Combs; P Weber; C Gerontis; J D DeCristofaro
Journal:  Pediatrics       Date:  2001-04       Impact factor: 7.124

7.  Oxygen-induced retinopathy in the mouse.

Authors:  L E Smith; E Wesolowski; A McLellan; S K Kostyk; R D'Amato; R Sullivan; P A D'Amore
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-01       Impact factor: 4.799

8.  Vaso-obliteration in the canine model of oxygen-induced retinopathy.

Authors:  D S McLeod; R Brownstein; G A Lutty
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-02       Impact factor: 4.799

9.  Dual and opposing roles of ERK in regulating G(1) and S-G(2)/M delays in A549 cells caused by hyperoxia.

Authors:  Jen-Chung Ko; Yi-Ting Wang; Jia-Ling Yang
Journal:  Exp Cell Res       Date:  2004-07-15       Impact factor: 3.905

10.  Astrocyte-endothelial cell relationships during human retinal vascular development.

Authors:  Tailoi Chan-Ling; D Scott McLeod; Suzanne Hughes; Louise Baxter; Yi Chu; Takuya Hasegawa; Gerard A Lutty
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-06       Impact factor: 4.799

View more
  16 in total

1.  Wound angiogenesis as a function of tissue oxygen tension: a mathematical model.

Authors:  Richard C Schugart; Avner Friedman; Rui Zhao; Chandan K Sen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-12       Impact factor: 11.205

2.  eNOS overexpression exacerbates vascular closure in the obliterative phase of OIR and increases angiogenic drive in the subsequent proliferative stage.

Authors:  Kevin Edgar; Thomas A Gardiner; Rien van Haperen; Rini de Crom; Denise M McDonald
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-03       Impact factor: 4.799

3.  Docosahexaenoic acid improves the nitroso-redox balance and reduces VEGF-mediated angiogenic signaling in microvascular endothelial cells.

Authors:  Nuria Matesanz; Grace Park; Hollie McAllister; William Leahey; Adrian Devine; Gary E McVeigh; Tom A Gardiner; Denise M McDonald
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-08-11       Impact factor: 4.799

4.  Reduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration.

Authors:  Hu Huang; Sara Van de Veire; Mansi Dalal; Rachel Parlier; Richard D Semba; Peter Carmeliet; Stanley A Vinores
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

Review 5.  Oxygen Regulation in Development: Lessons from Embryogenesis towards Tissue Engineering.

Authors:  Shahrzad Fathollahipour; Pritam S Patil; Nic D Leipzig
Journal:  Cells Tissues Organs       Date:  2018-10-01       Impact factor: 2.481

6.  Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity.

Authors:  Manabu McCloskey; Haibo Wang; Yanchao Jiang; George Wesley Smith; Jeremy Strange; M Elizabeth Hartnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-21       Impact factor: 4.799

Review 7.  The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 50/10 OIR model.

Authors:  M Elizabeth Hartnett
Journal:  Doc Ophthalmol       Date:  2009-07-29       Impact factor: 2.379

8.  Peroxisome proliferator-activated receptor-g agonist treatment increases septation and angiogenesis and decreases airway hyperresponsiveness in a model of experimental neonatal chronic lung disease.

Authors:  K Takeda; M Okamoto; S de Langhe; E Dill; M Armstrong; N Reisdorf; D Irwin; M Koster; J Wilder; K R Stenmark; J West; D Klemm; E W Gelfand; E Nozik-Grayck; S M Majka
Journal:  Anat Rec (Hoboken)       Date:  2009-07       Impact factor: 2.064

9.  Role of Nrf2 in retinal vascular development and the vaso-obliterative phase of oxygen-induced retinopathy.

Authors:  Koichi Uno; Tarl W Prow; Imran A Bhutto; Adi Yerrapureddy; D Scott McLeod; Masayuki Yamamoto; Sekhar P Reddy; Gerard A Lutty
Journal:  Exp Eye Res       Date:  2010-01-11       Impact factor: 3.467

10.  Modulating temporal and spatial oxygenation over adherent cellular cultures.

Authors:  Shawn C Oppegard; Ki-Hwan Nam; Janai R Carr; Stacey C Skaalure; David T Eddington
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.